• Users Online: 4151
  • Print this page
  • Email this page
CASE REPORT
Year : 2022  |  Volume : 5  |  Issue : 2  |  Page : 83-87

Cavitating lung cancer with underlying lung fibrosis treated as case of post-COVID-19 lung fibrosis with invasive mucormycosis


1 Department of Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra, India
2 Department of Internal Medicine, MIMSR Medical College, Latur, Maharashtra, India

Correspondence Address:
Dr. Shital Patil
Department of Pulmonary Medicine, MIMSR Medical College, Latur, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/japt.japt_26_22

Rights and Permissions

The pulmonary cavity is caused by infective, inflammatory, and malignant lung pathologies. In the currently ongoing COVID-19 pandemic, the most common cause for pulmonary cavities would be tuberculosis and fungal infections in the presence of exposure of high-dose steroids given during the course of hospitalization for COVID-19 pneumonia. In the present case report, an 86-year-old male presented with cavitating lung mass with hemoptysis who had received high-dose steroids for acute hypoxic respiratory failure due to COVID-19 pneumonia. He was treated with high-dose steroids during and after hospitalization for post-COVID-19 lung fibrosis with oxygen dependency and continuous oxygen supplementation. The right upper lobe mass was underevaluated, and developed cavitating consolidation in 3 months. He was evaluated and treated as a case of right upper lobe invasive aspergillosis and mucormycosis infection documented on sputum culture. He was treated with amphotericin B and higher antibiotics and discharged with oral voriconazole. Intermittent hemoptysis was a clinical clue to workup further with bronchoscopy for protocolized diagnosis of cavitating lung mass. Bronchoscopy documented moderately to poorly differentiated squamous cell carcinoma as a cause for cavitating consolidation. A high index of suspicion is must while dealing with pulmonary cavities. The currently ongoing COVID-19 pandemic may result in an underestimation of malignancy as a cause for cavitating lung pathology due to the rampant use of steroids during treatment of these cases and more documentation of fungal lung infections in post-COVID-19 care settings. We recommend bronchoscopy in cavitating lung disease for exact 'etiopathology documentation' of tropical and or malignant lung disease.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed86    
    Printed36    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal